Neurotrope (NTRP) ROE US GAAP (year values) |
|||||||||
2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
ROE, % | ? | -41.6% | -86.9% | -100.7% | -57.4% | -171.3% | -297.7% | ||
Changes by years, y/y, % | +43pp | -45pp | -14pp | +43pp | -114pp | +15.1% |
Neurotrope. ROE, %
Neurotrope. ROE, changes, pp
Neurotrope (NTRP) ROE US GAAP (quarter values) |
||||||||
2020Q3 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
ROE, % | ? | -44.4% | -230.3% | -306.6% | -387.9% | -297.7% | -297.7% | |
Changes by years, y/y, % | +41pp | |||||||
Changes by quarters, q/q, % | -4pp | -186pp | -76pp | -81pp | +90pp |